当前位置:
X-MOL 学术
›
Nat. Rev. Endocrinol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Thyroid cancer: Lenvatinib - beyond trials.
Nature Reviews Endocrinology ( IF 31.0 ) Pub Date : 2017-11-09 , DOI: 10.1038/nrendo.2017.149 Claire Greenhill
Nature Reviews Endocrinology ( IF 31.0 ) Pub Date : 2017-11-09 , DOI: 10.1038/nrendo.2017.149 Claire Greenhill
Thyroid cancer: Lenvatinib — beyond trials
中文翻译:
甲状腺癌:Lenvatinib-尚无试验。
甲状腺癌:Lenvatinib-超出试验范围
更新日期:2017-11-10
Thyroid cancer: Lenvatinib — beyond trials, Published online: 09 November 2017; doi:10.1038/nrendo.2017.149
中文翻译:
甲状腺癌:Lenvatinib-尚无试验。
甲状腺癌:Lenvatinib-超出试验范围
甲状腺癌:Lenvatinib-超出试验范围,在线发布:2017年11月9日;doi:10.1038 / nrendo.2017.149